BRPI0822651A2 - Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos - Google Patents

Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos

Info

Publication number: BRPI0822651A2
Authority: BR; Brazil
Prior art keywords: sadv; subfamily; adenovirus; adenovirus subfamily
Prior art date: 2007-11-28

Application number

BRPI0822651-2A2A

Other languages

English (en)

Inventor

Soumitra Roy

James M Wilson

Luc H Vandenberghe

Original Assignee

Univ Pennsylvania

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-28

Filing date

2008-11-24

Publication date

2014-10-14

2008-11-24 Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania

2014-10-14 Publication of BRPI0822651A2 publication Critical patent/BRPI0822651A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
- C12N2810/6018—Adenoviridae
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0822651-2A2A 2007-11-28 2008-11-24 Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos BRPI0822651A2 (pt)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US453307P	2007-11-28	2007-11-28
US446607P	2007-11-28	2007-11-28
US453107P	2007-11-28	2007-11-28
US453407P	2007-11-28	2007-11-28
US454207P	2007-11-28	2007-11-28
US456707P	2007-11-28	2007-11-28
PCT/US2008/013065 WO2009073103A2 (en)	2007-11-28	2008-11-24	Simian subfamily b adenoviruses sadv-28,27,-29,-32,-33, and -35 and uses thereof

Publications (1)

Publication Number	Publication Date
BRPI0822651A2 true BRPI0822651A2 (pt)	2014-10-14

Family

ID=40718407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0822651-2A2A BRPI0822651A2 (pt)	2007-11-28	2008-11-24	Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos

Country Status (20)

Country	Link
US (3)	US8524219B2 (pt)
EP (1)	EP2220242B1 (pt)
JP (3)	JP5740157B2 (pt)
KR (3)	KR101761683B1 (pt)
CN (1)	CN101883857B (pt)
AU (2)	AU2008331905B2 (pt)
BR (1)	BRPI0822651A2 (pt)
CA (1)	CA2706257C (pt)
CY (1)	CY1118866T1 (pt)
DK (1)	DK2220242T3 (pt)
ES (1)	ES2621165T3 (pt)
HR (1)	HRP20170395T1 (pt)
HU (1)	HUE031636T2 (pt)
LT (1)	LT2220242T (pt)
MX (2)	MX2010005859A (pt)
PL (1)	PL2220242T3 (pt)
PT (1)	PT2220242T (pt)
SG (2)	SG186022A1 (pt)
SI (1)	SI2220242T1 (pt)
WO (1)	WO2009073103A2 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5740158B2 (ja) *	2007-11-28	2015-06-24	ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア	サルＥアデノウイルスＳＡｄＶ−３９、−２５．２、−２６、−３０、−３７および−３８
CN102016011B (zh) *	2008-03-04	2013-12-11	宾夕法尼亚大学托管会	猿猴腺病毒sadv-36、-42.1、-42.2和-44及其应用
US8940290B2 (en)	2008-10-31	2015-01-27	The Trustees Of The University Of Pennsylvania	Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
EP2435559A1 (en)	2009-05-29	2012-04-04	The Trustees Of The University Of Pennsylvania	Simian adenovirus 41 and uses thereof
WO2012071318A2 (en)	2010-11-23	2012-05-31	The Trustees Of The University Of Pennsylvania	Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof
TWI623618B (zh)	2011-07-12	2018-05-11	傳斯堅公司	Ｈｂｖ聚合酶突變體
TW201321016A (zh)	2011-09-29	2013-06-01	Transgene Sa	免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二）
WO2013045658A1 (en)	2011-09-29	2013-04-04	Transgene Sa	Immunotherapy composition and regimen for treating hepatitis c virus infection
MX358019B (es)	2012-05-18	2018-08-02	Univ Pennsylvania	Adenovirus de simio de la subfamilia e a1302, a1320, a1331 y a1337 y sus usos.
KR102089121B1 (ko)	2013-03-14	2020-03-13	더 솔크 인스티튜트 포 바이올로지칼 스터디즈	종양살상형 아데노바이러스 조성물
EP3151866B1 (en)	2014-06-09	2023-03-08	Voyager Therapeutics, Inc.	Chimeric capsids
SG10202007103TA (en)	2014-11-05	2020-09-29	Voyager Therapeutics Inc	Aadc polynucleotides for the treatment of parkinson's disease
KR20230145206A (ko)	2014-11-14	2023-10-17	보이저 테라퓨틱스, 인크.	조절성 폴리뉴클레오티드
EP3218484A4 (en)	2014-11-14	2018-05-30	Voyager Therapeutics, Inc.	Compositions and methods of treating amyotrophic lateral sclerosis (als)
US11697825B2 (en)	2014-12-12	2023-07-11	Voyager Therapeutics, Inc.	Compositions and methods for the production of scAAV
WO2016131945A1 (en)	2015-02-20	2016-08-25	Transgene Sa	Combination product with autophagy modulator
BE1024420B1 (fr) *	2015-06-12	2018-02-19	Glaxosmithkline Biologicals Sa	Polynucleotides et polypeptides d'adenovirus
AU2016362477A1 (en)	2015-12-02	2018-06-14	Voyager Therapeutics, Inc.	Assays for the detection of AAV neutralizing antibodies
CA3013639A1 (en)	2016-02-23	2017-08-31	Salk Institute For Biological Studies	Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
EP3390428B1 (en)	2016-02-23	2019-09-25	Salk Institute for Biological Studies	High throughput assay for measuring adenovirus replication kinetics
EP3448987A4 (en)	2016-04-29	2020-05-27	Voyager Therapeutics, Inc.	COMPOSITIONS FOR THE TREATMENT OF DISEASES
EP3448874A4 (en)	2016-04-29	2020-04-22	Voyager Therapeutics, Inc.	COMPOSITIONS FOR TREATING A DISEASE
WO2017191147A1 (en)	2016-05-04	2017-11-09	Transgene Sa	Combination therapy with cpg tlr9 ligand
WO2017201248A1 (en)	2016-05-18	2017-11-23	Voyager Therapeutics, Inc.	Modulatory polynucleotides
EP3458589A4 (en)	2016-05-18	2020-01-01	Voyager Therapeutics, Inc.	COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
IL264872B1 (en)	2016-08-18	2024-10-01	Univ California	CRISPR-CAS genome engineering using a modular AAV delivery system
EP3831281A1 (en)	2016-08-30	2021-06-09	The Regents of The University of California	Methods for biomedical targeting and delivery and devices and systems for practicing the same
WO2018069316A2 (en)	2016-10-10	2018-04-19	Transgene Sa	Immunotherapeutic product and mdsc modulator combination therapy
JP2019536468A (ja)	2016-12-12	2019-12-19	ソークインスティテュートフォーバイオロジカルスタディーズ	腫瘍を標的にする合成アデノウイルスおよびその使用
SG11201909868YA (en)	2017-05-05	2019-11-28	Voyager Therapeutics Inc	Compositions and methods of treating huntington's disease
WO2018204786A1 (en)	2017-05-05	2018-11-08	Voyager Therapeutics, Inc.	Compositions and methods of treating amyotrophic lateral sclerosis (als)
JOP20190269A1 (ar)	2017-06-15	2019-11-20	Voyager Therapeutics Inc	بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en)	2017-07-17	2019-01-24	Voyager Therapeutics, Inc.	Trajectory array guide system
JP7221275B2 (ja)	2017-08-03	2023-02-13	ボイジャーセラピューティクスインコーポレイテッド	Ａａｖを送達するための組成物および方法
EP3697908A1 (en)	2017-10-16	2020-08-26	Voyager Therapeutics, Inc.	Treatment of amyotrophic lateral sclerosis (als)
AU2018352236A1 (en)	2017-10-16	2020-04-23	The Curators Of The University Of Missouri	Treatment of amyotrophic lateral sclerosis (ALS)
EP3807404A1 (en)	2018-06-13	2021-04-21	Voyager Therapeutics, Inc.	Engineered 5' untranslated regions (5' utr) for aav production
AU2019304569B2 (en)	2018-07-17	2023-07-06	Helixmith Co., Ltd	Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms
JP2021530548A (ja)	2018-07-24	2021-11-11	ボイジャーセラピューティクスインコーポレイテッドVoyager Therapeutics, Inc.	遺伝子治療製剤を生産するための系および方法
WO2020072849A1 (en)	2018-10-04	2020-04-09	Voyager Therapeutics, Inc.	Methods for measuring the titer and potency of viral vector particles
EP3861107A1 (en)	2018-10-05	2021-08-11	Voyager Therapeutics, Inc.	Engineered nucleic acid constructs encoding aav production proteins
US20210395777A1 (en)	2018-10-15	2021-12-23	Voyager Therapeutics, Inc.	EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM
AU2020216480A1 (en)	2019-01-31	2021-09-09	Oregon Health & Science University	Methods for using transcription-dependent directed evolution of AAV capsids
NL2023464B1 (en) *	2019-07-09	2021-02-02	Academisch Ziekenhuis Leiden	Oncolytic Non-human adenoviruses and uses thereof
TW202217002A (zh)	2020-07-13	2022-05-01	法商傳斯堅公司	免疫抑制之治療
AU2022214429A1 (en)	2021-02-01	2023-09-14	Regenxbio Inc.	Gene therapy for neuronal ceroid lipofuscinoses
WO2022218997A1 (en)	2021-04-12	2022-10-20	Centre National De La Recherche Scientifique (Cnrs)	Novel universal vaccine presenting system
WO2023173114A2 (en) *	2022-03-10	2023-09-14	Technovax, Inc.	Recombinant virus-like particle capsid vaccines against adenoviruses and compositions, methods, and use thereof
WO2023213764A1 (en)	2022-05-02	2023-11-09	Transgene	Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
CN117143833B (zh) *	2023-08-21	2024-06-04	暨南大学	一种猴腺病毒毒株及其应用
CN117089577B (zh) *	2023-08-21	2024-06-25	暨南大学	重组的猴腺病毒、病毒载体及构建方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2009A (en) *		1841-03-18		Improvement in machines for boring war-rockets
US2008A (en) *		1841-03-18		Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
WO1998010087A1 (en)	1996-09-06	1998-03-12	Trustees Of The University Of Pennsylvania	Chimpanzee adenovirus vectors
AU1822499A (en)	1997-12-12	1999-06-28	Saint Louis University	Ctip, a novel protein that interacts with ctbp and uses therefor
AU2002322285A1 (en)	2001-06-22	2003-01-08	The Trustees Of The University Of Pennsylvania	Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
US20040136963A1 (en)	2001-06-22	2004-07-15	The Trustees Of The University Of Pennsylvania	Simian adenovirus vectors and methods of use
US20040241181A1 (en) *	2001-06-22	2004-12-02	Ertl Hildeghund C. J.	Methods of inducing a cytotoxic immune response and recormbinant simian adenovirus compositions useful therein
CA2852277C (en)	2001-11-21	2018-02-20	Guangping Gao	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
US7291498B2 (en)	2003-06-20	2007-11-06	The Trustees Of The University Of Pennsylvania	Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
ES2478625T3 (es) *	2003-06-20	2014-07-22	The Trustees Of The University Of Pennsylvania	Método de generación de adenovirus quiméricos y usos de tales adenovirus quiméricos
DK1711518T3 (da)	2004-01-23	2010-04-06	Angeletti P Ist Richerche Bio	Vaccinebærere for chimpanse-adenovirus
EP1718315A4 (en) *	2004-02-06	2008-08-13	Univ Monash	HIGH-DOSE USE AND SHORT INTERVAL OF SULFATE POLYSACCHARIDES IN THE TREATMENT OF INFECTIONS
RS52187B (en) *	2004-10-14	2012-10-31	Crucell Holland B.V.	Vaccines for the induction and stimulation of the immune response for malaria
JP5175178B2 (ja)	2005-05-12	2013-04-03	グラクソグループリミテッド	ワクチン組成物
US20090074810A1 (en)	2006-04-28	2009-03-19	The Trustees Of The University Of Pennsylvania	Modified Adenovirus Hexon Protein and Uses Thereof
JP5740158B2 (ja)	2007-11-28	2015-06-24	ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア	サルＥアデノウイルスＳＡｄＶ−３９、−２５．２、−２６、−３０、−３７および−３８
JP5758124B2 (ja)	2007-11-28	2015-08-05	ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア	サルサブファミリーＣアデノウイルスＳＡｄＶ−４０、−３１および−３４ならびにそれらの用途

2008
- 2008-11-24 BR BRPI0822651-2A2A patent/BRPI0822651A2/pt not_active Application Discontinuation
- 2008-11-24 PT PT88577812T patent/PT2220242T/pt unknown
- 2008-11-24 CN CN200880118585.XA patent/CN101883857B/zh not_active Expired - Fee Related
- 2008-11-24 KR KR1020167026644A patent/KR101761683B1/ko active IP Right Grant
- 2008-11-24 MX MX2010005859A patent/MX2010005859A/es active IP Right Grant
- 2008-11-24 US US12/744,375 patent/US8524219B2/en active Active
- 2008-11-24 KR KR1020107014131A patent/KR101614362B1/ko not_active IP Right Cessation
- 2008-11-24 PL PL08857781T patent/PL2220242T3/pl unknown
- 2008-11-24 CA CA2706257A patent/CA2706257C/en not_active Expired - Fee Related
- 2008-11-24 SG SG2012085635A patent/SG186022A1/en unknown
- 2008-11-24 SI SI200831779A patent/SI2220242T1/sl unknown
- 2008-11-24 SG SG10201603993TA patent/SG10201603993TA/en unknown
- 2008-11-24 MX MX2013010573A patent/MX344106B/es unknown
- 2008-11-24 JP JP2010535986A patent/JP5740157B2/ja not_active Expired - Fee Related
- 2008-11-24 KR KR1020157025052A patent/KR101662571B1/ko active IP Right Grant
- 2008-11-24 EP EP08857781.2A patent/EP2220242B1/en not_active Not-in-force
- 2008-11-24 DK DK08857781.2T patent/DK2220242T3/en active
- 2008-11-24 LT LTEP08857781.2T patent/LT2220242T/lt unknown
- 2008-11-24 ES ES08857781.2T patent/ES2621165T3/es active Active
- 2008-11-24 HU HUE08857781A patent/HUE031636T2/en unknown
- 2008-11-24 WO PCT/US2008/013065 patent/WO2009073103A2/en active Application Filing
- 2008-11-24 AU AU2008331905A patent/AU2008331905B2/en not_active Ceased
2013
- 2013-08-16 US US13/968,757 patent/US9206238B2/en not_active Expired - Fee Related
2014
- 2014-12-05 JP JP2014246762A patent/JP2015107117A/ja active Pending
- 2014-12-16 AU AU2014277699A patent/AU2014277699B2/en not_active Ceased
2015
- 2015-11-03 US US14/931,286 patent/US20160051603A1/en not_active Abandoned
2016
- 2016-05-18 JP JP2016099658A patent/JP2016214242A/ja active Pending
2017
- 2017-03-10 HR HRP20170395TT patent/HRP20170395T1/hr unknown
- 2017-03-28 CY CY20171100382T patent/CY1118866T1/el unknown

Also Published As

Publication number	Publication date
KR20100109914A (ko)	2010-10-11
KR20150109495A (ko)	2015-10-01
PL2220242T3 (pl)	2017-09-29
JP2015107117A (ja)	2015-06-11
HUE031636T2 (en)	2017-07-28
AU2014277699B2 (en)	2017-04-06
KR101662571B1 (ko)	2016-10-05
KR20160119251A (ko)	2016-10-12
US20160051603A1 (en)	2016-02-25
KR101614362B1 (ko)	2016-04-22
CA2706257C (en)	2017-06-06
AU2014277699A1 (en)	2015-01-22
DK2220242T3 (en)	2017-03-27
SG186022A1 (en)	2012-12-28
AU2008331905B2 (en)	2014-09-18
WO2009073103A3 (en)	2010-05-20
JP5740157B2 (ja)	2015-06-24
CN101883857A (zh)	2010-11-10
AU2008331905A1 (en)	2009-06-11
ES2621165T3 (es)	2017-07-03
CY1118866T1 (el)	2018-01-10
EP2220242A2 (en)	2010-08-25
JP2016214242A (ja)	2016-12-22
LT2220242T (lt)	2017-04-10
US20140044680A1 (en)	2014-02-13
SI2220242T1 (sl)	2017-05-31
US20100254947A1 (en)	2010-10-07
MX2010005859A (es)	2010-06-11
MX344106B (es)	2016-12-05
WO2009073103A2 (en)	2009-06-11
HRP20170395T1 (hr)	2017-05-05
JP2011504750A (ja)	2011-02-17
EP2220242B1 (en)	2016-12-28
CN101883857B (zh)	2015-08-12
KR101761683B1 (ko)	2017-07-26
US9206238B2 (en)	2015-12-08
PT2220242T (pt)	2017-04-03
US8524219B2 (en)	2013-09-03
CA2706257A1 (en)	2009-06-11
SG10201603993TA (en)	2016-07-28

Publication	Publication Date	Title
BRPI0822651A2 (pt)	2014-10-14	Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos
BRPI0819774A2 (pt)	2014-10-14	Subfamília c de adenovírus sadv-40, -31 e -34 de símio e seus usos
NL1033936A1 (nl)	2007-12-11	Röntgen-CT-apparatuur.
NL1033652A1 (nl)	2007-10-09	Röntgen-CT-apparatuur.
NL1032581A1 (nl)	2007-03-28	Röntgen CT-apparatuur.
BRPI0815452A2 (pt)	2015-02-18	"equipamento para gastropexia"
BRPI0910627A2 (pt)	2015-09-22	composições de alta densidade contendo posaconazol e formulações compreendendo as mesmas
SI2217578T1 (sl)	2014-03-31	(1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba
BRPI0922384A2 (pt)	2016-01-26	"manipulador de suprimento para equipamento".
BRPI0923725A2 (pt)	2015-08-04	"compostos absorventes de uv trifuncionais e uso dos mesmos".
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI0815564A2 (pt)	2015-02-18	Anticorpos que inibem a dimerização de c-met e usos dos mesmos.
BRPI0718688A2 (pt)	2013-12-24	Composições de baixa irritação e métodos para preparar as mesmas.
PT2134699E (pt)	2011-08-25	Compostos de 2-aril-5-heterociclil-ciclo-hexano-1,3-diona e sua utilização como herbicidas
BRPI0813341A2 (pt)	2014-12-23	" uso de compostos, composições curáveis, e, uso de composições curáveis ".
NL1032782A1 (nl)	2007-05-02	Röntgendetector en röntgen-CT-apparatuur.
BRPI0907365A2 (pt)	2015-07-14	Composição antimicrobiana e uso
IT1397595B1 (it)	2013-01-16	Sostanze coloranti e loro utilizzazione in composizioni, in particolare in composizioni cosmetiche.
NL1034066A1 (nl)	2008-01-03	Röntgen-CT-apparatuur.
BRPI0920953A2 (pt)	2015-12-29	dispositivo de manutenção, e uso do mesmo.
NL1032916A1 (nl)	2007-05-23	Röntgen CT toestel.
BRPI0820200A2 (pt)	2015-06-23	Composições de emulsão e composição de emulsão agroquímica
BRPI0815768A2 (pt)	2014-09-30	Uso de absorventes de uv, e, composição cosmética.
BRPI0813922A2 (pt)	2017-05-09	composições de inibição de influenza e métodos.
BRPI0916943A2 (pt)	2015-11-24	composição lubrificante, e, uso da mesma

Legal Events

Date	Code	Title	Description
2017-03-01	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2017-07-04	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-07-24	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-11-06	B09B	Patent application refused [chapter 9.2 patent gazette]
2019-01-22	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL
2022-07-12	B350	Update of information on the portal [chapter 15.35 patent gazette]